243 related articles for article (PubMed ID: 32170446)
1. Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
Iizuka T; Kameyama M
J Neurol; 2020 Jul; 267(7):1960-1969. PubMed ID: 32170446
[TBL] [Abstract][Full Text] [Related]
2. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
Nedelska Z; Senjem ML; Przybelski SA; Lesnick TG; Lowe VJ; Boeve BF; Arani A; Vemuri P; Graff-Radford J; Ferman TJ; Jones DT; Savica R; Knopman DS; Petersen RC; Jack CR; Kantarci K
Neuroimage Clin; 2018; 19():939-947. PubMed ID: 30003031
[TBL] [Abstract][Full Text] [Related]
3. Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies.
Pillai JA; Wu G; Tousi B; Larvie M; Léger GC; Leverenz JB
Parkinsonism Relat Disord; 2019 Jul; 64():300-303. PubMed ID: 30905401
[TBL] [Abstract][Full Text] [Related]
4. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
[TBL] [Abstract][Full Text] [Related]
5. Evaluating 2-[
Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.
Imai M; Tanaka M; Sakata M; Wagatsuma K; Tago T; Toyohara J; Sengoku R; Nishina Y; Kanemaru K; Ishibashi K; Murayama S; Ishii K
J Alzheimers Dis; 2020; 73(1):197-207. PubMed ID: 31771066
[TBL] [Abstract][Full Text] [Related]
7. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
Iizuka T; Kameyama M
Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
[TBL] [Abstract][Full Text] [Related]
8. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
[TBL] [Abstract][Full Text] [Related]
9. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
[TBL] [Abstract][Full Text] [Related]
10. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
[TBL] [Abstract][Full Text] [Related]
11. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
[TBL] [Abstract][Full Text] [Related]
12.
Whitwell JL; Graff-Radford J; Singh TD; Drubach DA; Senjem ML; Spychalla AJ; Tosakulwong N; Lowe VJ; Josephs KA
J Nucl Med; 2017 Apr; 58(4):632-638. PubMed ID: 27688479
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
Ye BS; Lee S; Yoo H; Chung SJ; Lee YH; Choi Y; Lee PH; Sohn YH; Yun M
Neurobiol Aging; 2020 Mar; 87():11-17. PubMed ID: 31791660
[TBL] [Abstract][Full Text] [Related]
14. Brain
Woyk K; Sahlmann CO; Hansen N; Timäus C; Müller SJ; Khadhraoui E; Wiltfang J; Lange C; Bouter C
J Neuroimaging; 2023 Mar; 33(2):256-268. PubMed ID: 36465027
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
Gilman S; Koeppe RA; Little R; An H; Junck L; Giordani B; Persad C; Heumann M; Wernette K
Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
[TBL] [Abstract][Full Text] [Related]
16. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
Kantarci K; Lowe VJ; Boeve BF; Senjem ML; Tosakulwong N; Lesnick TG; Spychalla AJ; Gunter JL; Fields JA; Graff-Radford J; Ferman TJ; Jones DT; Murray ME; Knopman DS; Jack CR; Petersen RC
Ann Neurol; 2017 Jan; 81(1):58-67. PubMed ID: 27863444
[TBL] [Abstract][Full Text] [Related]
17. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
[TBL] [Abstract][Full Text] [Related]
18. Alteration of medial temporal lobe metabolism related to Alzheimer's disease and dementia with lewy bodies.
Kang S; Jeon S; Lee YG; Ye BS
Alzheimers Res Ther; 2024 Apr; 16(1):89. PubMed ID: 38654300
[TBL] [Abstract][Full Text] [Related]
19. Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
Carli G; Meles SK; Reesink FE; de Jong BM; Pilotto A; Padovani A; Galbiati A; Ferini-Strambi L; Leenders KL; Perani D
Neuroimage Clin; 2023; 39():103475. PubMed ID: 37494757
[TBL] [Abstract][Full Text] [Related]
20. Clinical validation of the cingulate island sign visual rating scale in dementia with Lewy bodies.
Feng LR; Vogel A; Mellergaard C; Waldemar G; Hasselbalch SG; Law I; Henriksen OM; Frederiksen KS
J Neurol Sci; 2023 Aug; 451():120719. PubMed ID: 37421880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
